Evoke Pharma (NASDAQ: EVOK) reported Q3 EPS of ($0.51), $0.11 better than the analyst estimate of ($0.62). Revenue for the quarter came in at $1.56 million versus the consensus estimate of $1.26 million.

For earnings history and earnings-related data on Evoke Pharma (EVOK) click here.